GL Pharm Tech Sets Record Date for Shareholder Opposition Rights in Small-Scale Merger with 100% Subsidiary… No Value Impact

GL Pharm Tech announced it has set the record date as June 12, 2026, to determine shareholders entitled to oppose the small-scale merger with its wholly-owned subsidiary GL Pharma.
This record date is a procedural step to identify shareholders holding 20% or more of total issued shares who can exercise opposition rights, as appraisal rights are not granted in small-scale mergers.
The merger will be executed without issuing new shares, resulting in zero dilution for existing shareholders and no change in control.
However, if shareholders with a 20% or higher stake (e.g., major shareholder W Science with 29.77%) submit a written objection as of the record date, the merger may convert to a general procedure, which investors should monitor.